[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367149-105":59,"doc-detail-367149-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","pan-cancer-and-multi-omics-analysis-ndufa1-is-a-potential-therapeutic-target-and-prognostic-marker-for-esophageal-cancer","Pan-cancer and multi-omics analysis - NDUFA1 is a potential therapeutic target and prognostic marker for esophageal cancer","","The study evaluates NDUFA1 expression across pan-cancer and clarifies its prognostic significance, with focused investigation in esophageal cancer (ESCA). Using TCGA data from 33 cancer types, the work assesses clinical correlations and performs GO/KEGG enrichment for NDUFA1-related genes. Functional experiments in ESCA cell lines (KYSE-30) and a xenograft mouse model validate that NDUFA1 contributes to malignant phenotypes and links to PI3K-Akt pathway activity.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-and-multi-omics-analysis-ndufa1-is-a-potential-therapeutic-target-and-prognostic-marker-for-esophageal-cancer/367149/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-and-multi-omics-analysis-ndufa1-is-a-potential-therapeutic-target-and-prognostic-marker-for-esophageal-cancer/367149.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study on NDUFA1?","Question",{"text":113,"@type":114},"The study examines NDUFA1 expression and its prognostic value in pan-cancer, with particular emphasis on ESCA, and further explores its carcinogenic role in ESCA.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was NDUFA1 expression and prognosis evaluated?",{"text":118,"@type":114},"NDUFA1 expression and prognostic associations were analyzed using the TCGA database across 33 cancer types, and ESCA tumor tissues were specifically assessed.",{"name":120,"@type":111,"acceptedAnswer":121},"What experimental evidence supports NDUFA1’s role in ESCA?",{"text":122,"@type":114},"NDUFA1 knockdown reduced ESCA cell proliferation, migration, and invasion, inhibited tumor growth in xenograft mice, and reversed activated PI3K-Akt signaling in ESCA cell lines and tumor tissues.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},367149,1790503701,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Cell Biol Toxicol (2025) 41:43  \n[https://doi.org/10.1007/s10565-025-09993-7](https://doi.org/10.1007/s10565-025-09993-7)  \nPan‑cancer and multi‑omics analysis: NDUFA1  \nis a potential therapeutic target and prognostic marker for esophageal cancer  \nRui Yin · Gai Zhou · Guanqi Liu · Xiaoting Hou · Haifeng Yang ·  \nJianxin Ge · Jie Ying  \nReceived: 9 August 2024 / Accepted: 28 January 2025  \n© The Author(s) 2025  \nAbstract  \nObjectives The study examined the NDUFA1 expression and its prognostic value in pan-cancer, especially in esophageal cancer (ESCA) . Its carcinogenic effect on ESCA was further elucidated. Materials and methods TCGA database was used to examine NDUFA1 expression and its prognostic value in 33 cancer types. GO and KEGG were performed for function and pathway enrichment of NDUFA1-related genes. The carcinogenic effect on ESCA was verified in both KYSE-30 cell and Xenograft mouse model.  \n\n| Rui Yin, Gai Zhou, and Guanqi Liu was contributed equally to the study. |\n| --- |\n| Supplementary Information The online version contains supplementary material available at [https://doi](https://doi). org/10.1007/s10565-025-09993-7. |\n\nR. Yin · G. Zhou · G. Liu · X. Hou · J. Ge (*) ·  \nJ. Ying (*)  \nDepartment of Gastroenterology, Nanjing Jiangbei Hospital, Nanjing 210044, China  \ne-mail: [gejianxin2024@163.com](gejianxin2024@163.com)  \n[J. Ying](J. Ying)  \n[e-mail: yj_8611@163.com](e-mail: yj_8611@163.com)  \nR. Yin · G. Zhou · G. Liu · X. Hou · J. Ge · J. Ying Department of Gastroenterology, Affiliated Nanjing Jiangbei Hospital of Xinglin College, Nantong University, No. 552, Geguan Road, Jiangbei New District, Nanjing 210044, China  \nResults Abnormal high expression of NDUFA1 was detected in pan-cancer, and related to immune cell infiltration. TCGA database indicated an elevated value of NDUFA1 in ESCA tumor tissues, which was linked to patients’ poor prognosis. NDUFA1-related genes were mainly enriched in oxidative stress and immune response in ESCA. NDUFA1 knockdown significantly suppressed ESCA cell proliferation, migration and invasion. Similarly, tumor growth of ESCA xenograft mice was inhibited by NDUFA1 knockdown. Activated PI3K-Akt signaling was detected in both ESCA cell lines and tumor tissues, which was reversed by NDUFA1 knockdown.  \nConclusion Multi-omics analysis showed that NDUFA1 might be adopted as a potential therapeutic goal and prognostic indicator for a variety of cancers, especially for ESCA. NDUFA1 knockdown inhibited ESCA tumor growth, which may have the participation of the PI3K/Akt signaling pathway.  \nKeywords NDUFA1 · Pan-cancer · ESCA · Immune cell infiltration · PI3K/Akt  \nH. Yang (*)  \nDepartment of Infectious Disease, Economic Development Zone, People’s Hospital of Xuyi, No. 28, Hongwu Avenue, Xuyi 211700, China  \ne-mail: [ymhxpy@163.com](ymhxpy@163.com)  \nIntroduction  \nEsophageal cancer (ESCA) ranks among the most prevalent esophageal tumors (Huang and Yu 2018) . Since no obvious clinical symptoms and lack specific early diagnosis markers in clinic, most ESCA patients are usually diagnosed in the middle or late stages with a high mortality rate (Zhu et al. 2023) . Even with the help of surgery and other adjuvant treatments such as chemotherapeutics, radiation, and molecular targeted therapy, the rate of survival over a five-year period for ESCA patients is just 20% to 25%(Domper Arnalet al. 2015) . It can be seen that early diagnosis and treatment are crucial so as to boost the survival rate of ESCA patients. Currently, the diagnosis of ESCAis mainly through endoscopy combined with pathological biopsy (Ishihara 2022) . However, endoscopic screening cannot be universally accepted because it is costly (Kelly 2019) . Consequently, it is urgently required to find novel ESCA biomarkers with early diagnostic value, and provide a more simple and noninvasive method for clinical use.  \nMolecular detection is beneficial to the early screening of high-risk ESCC population and it is instrumental in","cbCaivvIPB9PWs7Q","https://ap.wps.com/l/cbCaivvIPB9PWs7Q","pdf",8954297,"English","# Abstract\n## Objectives and scope\n## Materials and methods\n## Key results\n## Conclusion\n# Introduction\n## Clinical need for biomarkers in ESCA\n## Current diagnostic approaches and limitations\n## Background on NDUFA1 and mitochondrial complex I","[{\"question\":\"What is the main objective of the study on NDUFA1?\",\"answer\":\"The study examines NDUFA1 expression and its prognostic value in pan-cancer, with particular emphasis on ESCA, and further explores its carcinogenic role in ESCA.\"},{\"question\":\"How was NDUFA1 expression and prognosis evaluated?\",\"answer\":\"NDUFA1 expression and prognostic associations were analyzed using the TCGA database across 33 cancer types, and ESCA tumor tissues were specifically assessed.\"},{\"question\":\"What experimental evidence supports NDUFA1’s role in ESCA?\",\"answer\":\"NDUFA1 knockdown reduced ESCA cell proliferation, migration, and invasion, inhibited tumor growth in xenograft mice, and reversed activated PI3K-Akt signaling in ESCA cell lines and tumor tissues.\"}]","Pan-cancer and multi-omics analysis - NDUFA1 is a potential therapeutic target and prognostic marker for esophageal cancer | PDF",1790169500,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a36b39c88b9c858551a90344d428318a.webp",983,1324,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/890372d05dd6e51e2211e0f04d774f97.webp",982,1322,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d44f6b27085015fca54ee7984f8abe4.webp",981,1321,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbd31a82d114f31c1b10e30693e7b997.webp",980,1319]